Literature DB >> 23792644

Level of Notch activation determines the effect on growth and stem cell-like features in glioblastoma multiforme neurosphere cultures.

Karina Kristoffersen1, Mette Villingshøj, Hans Skovgaard Poulsen, Marie-Thérése Stockhausen.   

Abstract

BACKGROUND: Brain cancer stem-like cells (bCSC) are cancer cells with neural stem cell (NSC)-like properties found in glioblastoma multiforme (GBM) and they are assigned a central role in tumor initiation, progression and relapse. The Notch pathway is important for maintenance and cell fate decisions in the normal NSC population. Notch signaling is often deregulated in GBM and recent results suggest that this pathway plays a significant role in bCSC as well. We therefore wished to further elucidate the role of Notch activation in GBM-derived bCSC.
METHODS: Human-derived GBM xenograft cells were cultured as NSC-like neurosphere cultures. Notch modulation was accomplished either by blocking the pathway using the γ-secretase inhibitor DAPT or by activating it by transfecting the cells with the constitutive active Notch-1 receptor.
RESULTS: GBM neurosphere cultures with high endogenous Notch activation displayed sensitivity toward Notch inhibition with regard to tumorigenic features as demonstrated by increased G0/G1 population and reduced colony formation capacity. Of the NSC-like characteristics, only the primary sphere forming potential was affected, while no effect was observed on self-renewal or differentiation. In contrast, when Notch signaling was activated a decrease in the G0/G1 population and an enhanced capability of colony formation was observed, along with increased self-renewal and de-differentiation.
CONCLUSION: Based on the presented results we propose that active Notch signaling plays a role for cell growth and stem cell-like features in GBM neurosphere cultures and that Notch-targeted anti-bCSC treatment could be feasible for GBM patients with high endogenous Notch pathway activation.

Entities:  

Keywords:  DAPT; ICN-1; Notch activity; Notch signaling; brain cancer stem-like cells; glioblastoma multiforme; neurosphere cultures

Mesh:

Substances:

Year:  2013        PMID: 23792644      PMCID: PMC3742492          DOI: 10.4161/cbt.24595

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  72 in total

1.  Cellular composition and cytoarchitecture of the adult human subventricular zone: a niche of neural stem cells.

Authors:  Alfredo Quiñones-Hinojosa; Nader Sanai; Mario Soriano-Navarro; Oscar Gonzalez-Perez; Zaman Mirzadeh; Sara Gil-Perotin; Richard Romero-Rodriguez; Mitchell S Berger; Jose Manuel Garcia-Verdugo; Arturo Alvarez-Buylla
Journal:  J Comp Neurol       Date:  2006-01-20       Impact factor: 3.215

2.  Inhibition of notch signaling in human embryonic stem cell-derived neural stem cells delays G1/S phase transition and accelerates neuronal differentiation in vitro and in vivo.

Authors:  Lodovica Borghese; Dasa Dolezalova; Thoralf Opitz; Simone Haupt; Anke Leinhaas; Barbara Steinfarz; Philipp Koch; Frank Edenhofer; Ales Hampl; Oliver Brüstle
Journal:  Stem Cells       Date:  2010-05       Impact factor: 6.277

3.  Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1.

Authors:  Roel G W Verhaak; Katherine A Hoadley; Elizabeth Purdom; Victoria Wang; Yuan Qi; Matthew D Wilkerson; C Ryan Miller; Li Ding; Todd Golub; Jill P Mesirov; Gabriele Alexe; Michael Lawrence; Michael O'Kelly; Pablo Tamayo; Barbara A Weir; Stacey Gabriel; Wendy Winckler; Supriya Gupta; Lakshmi Jakkula; Heidi S Feiler; J Graeme Hodgson; C David James; Jann N Sarkaria; Cameron Brennan; Ari Kahn; Paul T Spellman; Richard K Wilson; Terence P Speed; Joe W Gray; Matthew Meyerson; Gad Getz; Charles M Perou; D Neil Hayes
Journal:  Cancer Cell       Date:  2010-01-19       Impact factor: 31.743

4.  NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts.

Authors:  Xing Fan; Leila Khaki; Thant S Zhu; Mary E Soules; Caroline E Talsma; Naheed Gul; Cheryl Koh; Jiangyang Zhang; Yue-Ming Li; Jarek Maciaczyk; Guido Nikkhah; Francesco Dimeco; Sara Piccirillo; Angelo L Vescovi; Charles G Eberhart
Journal:  Stem Cells       Date:  2010-01       Impact factor: 6.277

5.  Neurosphere formation is an independent predictor of clinical outcome in malignant glioma.

Authors:  Dan R Laks; Michael Masterman-Smith; Koppany Visnyei; Brigitte Angenieux; Nicholas M Orozco; Ian Foran; William H Yong; Harry V Vinters; Linda M Liau; Jorge A Lazareff; Paul S Mischel; Timothy F Cloughesy; Steve Horvath; Harley I Kornblum
Journal:  Stem Cells       Date:  2009-04       Impact factor: 6.277

6.  Notch promotes radioresistance of glioma stem cells.

Authors:  Jialiang Wang; Timothy P Wakeman; Justin D Lathia; Anita B Hjelmeland; Xiao-Fan Wang; Rebekah R White; Jeremy N Rich; Bruce A Sullenger
Journal:  Stem Cells       Date:  2010-01       Impact factor: 6.277

7.  Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial.

Authors:  Roger Stupp; Monika E Hegi; Warren P Mason; Martin J van den Bent; Martin J B Taphoorn; Robert C Janzer; Samuel K Ludwin; Anouk Allgeier; Barbara Fisher; Karl Belanger; Peter Hau; Alba A Brandes; Johanna Gijtenbeek; Christine Marosi; Charles J Vecht; Karima Mokhtari; Pieter Wesseling; Salvador Villa; Elizabeth Eisenhauer; Thierry Gorlia; Michael Weller; Denis Lacombe; J Gregory Cairncross; René-Olivier Mirimanoff
Journal:  Lancet Oncol       Date:  2009-03-09       Impact factor: 41.316

8.  5'-Nitro-indirubinoxime induces G1 cell cycle arrest and apoptosis in salivary gland adenocarcinoma cells through the inhibition of Notch-1 signaling.

Authors:  Ji-Hye Yoon; Soo-A Kim; Seong-Min Kwon; Jong-Hwan Park; Hee-Sae Park; Yong-Chul Kim; Jung-Hoon Yoon; Sang-Gun Ahn
Journal:  Biochim Biophys Acta       Date:  2009-11-13

Review 9.  Neural stem cells, tumour stem cells and brain tumours: dangerous relationships?

Authors:  Reto Sutter; Gokhan Yadirgi; Silvia Marino
Journal:  Biochim Biophys Acta       Date:  2007-08-16

10.  Glioblastoma subclasses can be defined by activity among signal transduction pathways and associated genomic alterations.

Authors:  Cameron Brennan; Hiroyuki Momota; Dolores Hambardzumyan; Tatsuya Ozawa; Adesh Tandon; Alicia Pedraza; Eric Holland
Journal:  PLoS One       Date:  2009-11-13       Impact factor: 3.240

View more
  15 in total

1.  Phase I trial of weekly MK-0752 in children with refractory central nervous system malignancies: a pediatric brain tumor consortium study.

Authors:  Lindsey M Hoffman; Maryam Fouladi; James Olson; Vinay M Daryani; Clinton F Stewart; Cynthia Wetmore; Mehmet Kocak; Arzu Onar-Thomas; Lars Wagner; Sridharan Gururangan; Roger J Packer; Susan M Blaney; Amar Gajjar; Larry E Kun; James M Boyett; Richard J Gilbertson
Journal:  Childs Nerv Syst       Date:  2015-05-01       Impact factor: 1.475

2.  Inhibition of Notch signaling alters the phenotype of orthotopic tumors formed from glioblastoma multiforme neurosphere cells but does not hamper intracranial tumor growth regardless of endogene Notch pathway signature.

Authors:  Karina Kristoffersen; Mette Kjølhede Nedergaard; Mette Villingshøj; Rehannah Borup; Helle Broholm; Andreas Kjær; Hans Skovgaard Poulsen; Marie-Thérése Stockhausen
Journal:  Cancer Biol Ther       Date:  2014-04-22       Impact factor: 4.742

3.  Dysregulation of the PI3K/Akt signaling pathway affects cell cycle and apoptosis of side population cells in nasopharyngeal carcinoma.

Authors:  Danwei Zheng; Guangchao Zhu; Shan Liao; Wei Yi; Gengqiu Luo; Junyu He; Zhen Pei; Guiyuan Li; Yanhong Zhou
Journal:  Oncol Lett       Date:  2015-05-18       Impact factor: 2.967

4.  ASYMMETRIC CELL DIVISION: IMPLICATIONS FOR GLIOMA DEVELOPMENT AND TREATMENT.

Authors:  Kate Marie Lewis; Claudia Petritsch
Journal:  Transl Neurosci       Date:  2013-12       Impact factor: 1.757

5.  Differentiation of glioblastoma multiforme stem-like cells leads to downregulation of EGFR and EGFRvIII and decreased tumorigenic and stem-like cell potential.

Authors:  Marie-Thérése Stockhausen; Karina Kristoffersen; Louise Stobbe; Hans Skovgaard Poulsen
Journal:  Cancer Biol Ther       Date:  2013-11-01       Impact factor: 4.742

6.  Prevention against diffuse spinal cord astrocytoma: can the Notch pathway be a novel treatment target?

Authors:  Jian-Jun Sun; Zhen-Yu Wang; Ling-Song Li; Hai-Yan Yu; Yong-Sheng Xu; Hai-Bo Wu; Yi Luo; Bin Liu; Mei Zheng; Jin-Long Mao; Xiao-Hui Lou
Journal:  Neural Regen Res       Date:  2015-02       Impact factor: 5.135

7.  Sialidase NEU4 is involved in glioblastoma stem cell survival.

Authors:  I Silvestri; F Testa; R Zappasodi; C W Cairo; Y Zhang; B Lupo; R Galli; M Di Nicola; B Venerando; C Tringali
Journal:  Cell Death Dis       Date:  2014-08-21       Impact factor: 8.469

8.  The use of longitudinal 18F-FET MicroPET imaging to evaluate response to irinotecan in orthotopic human glioblastoma multiforme xenografts.

Authors:  Mette K Nedergaard; Karina Kristoffersen; Signe R Michaelsen; Jacob Madsen; Hans S Poulsen; Marie-Thérése Stockhausen; Ulrik Lassen; Andreas Kjaer
Journal:  PLoS One       Date:  2014-06-11       Impact factor: 3.240

9.  Epithelial-mesenchymal transition in glioblastoma progression.

Authors:  Yasuo Iwadate
Journal:  Oncol Lett       Date:  2016-01-14       Impact factor: 2.967

Review 10.  Signaling pathways and mesenchymal transition in pediatric high-grade glioma.

Authors:  Michaël H Meel; Sophie A Schaper; Gertjan J L Kaspers; Esther Hulleman
Journal:  Cell Mol Life Sci       Date:  2017-11-21       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.